HomeRSPI โข OTCMKTS
add
RespireRx
Previous close
$0.0018
Day range
$0.0018 - $0.0018
Year range
$0.00040 - $0.0027
Market cap
657.75K USD
Avg Volume
57.25K
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2022info | Y/Y change |
|---|---|---|
Revenue | โ | โ |
Operating expense | 1.58M | -38.29% |
Net income | -2.10M | 33.14% |
Net profit margin | โ | โ |
Earnings per share | โ | โ |
EBITDA | โ | โ |
Effective tax rate | โ | โ |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 88.00 | -93.71% |
Total assets | 22.78K | -89.09% |
Total liabilities | 11.90M | 16.51% |
Total equity | -11.88M | โ |
Shares outstanding | 144.33M | โ |
Price to book | -0.02 | โ |
Return on assets | -852.72% | โ |
Return on capital | 11.54% | โ |
Cash Flow
Net change in cash
| (USD) | 2022info | Y/Y change |
|---|---|---|
Net income | -2.10M | 33.14% |
Cash from operations | -143.90K | 84.95% |
Cash from investing | โ | โ |
Cash from financing | 142.60K | -85.10% |
Net change in cash | -1.31K | -328.62% |
Free cash flow | 389.00K | 311.12% |
About
RespireRx Pharmaceuticals Inc. is a pharmaceutical company based in Glen Rock, New Jersey specializing in positive allosteric modulators of the AMPA receptor known as Ampakines and cannabinoids. Wikipedia
Founded
1987
Headquarters
Website
Employees
2
